These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8616177)

  • 1. Treatment modality selection in 150 consecutive patients starting ESRD therapy.
    Prichard SS
    Perit Dial Int; 1996; 16(1):69-72. PubMed ID: 8616177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between dialysis modality selection and initiation.
    Liebman SE; Bushinsky DA; Dolan JG; Veazie P
    Am J Kidney Dis; 2012 Apr; 59(4):550-7. PubMed ID: 22305859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
    Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
    Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
    Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
    Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of peritoneal dialysis among older eligible patients with end-stage renal disease.
    Wong B; Venturato L; Oliver MJ; Quinn RR; Ravani P; Holroyd-Leduc J
    Nephrol Dial Transplant; 2017 Feb; 32(2):384-392. PubMed ID: 28186576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What influences patient choice of treatment modality at the pre-dialysis stage?
    Chanouzas D; Ng KP; Fallouh B; Baharani J
    Nephrol Dial Transplant; 2012 Apr; 27(4):1542-7. PubMed ID: 21865216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes.
    Jin H; Fang W; Zhu M; Yu Z; Fang Y; Yan H; Zhang M; Wang Q; Che X; Xie Y; Huang J; Hu C; Zhang H; Mou S; Ni Z
    PLoS One; 2016; 11(11):e0166181. PubMed ID: 27824950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands.
    Jager KJ; Korevaar JC; Dekker FW; Krediet RT; Boeschoten EW;
    Am J Kidney Dis; 2004 May; 43(5):891-9. PubMed ID: 15112180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the use of peritoneal dialysis among the ESRD population in India: a single-center study.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK
    Perit Dial Int; 2004; 24(6):538-41. PubMed ID: 15559482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Options in uraemia therapy for diabetics with end-stage renal disease.
    Polenaković MH
    Prilozi; 2004; 25(1-2):27-51. PubMed ID: 15735534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.
    Guilloteau S; Lobbedez T; Guillouët S; Verger C; Ficheux M; Lanot A; Béchade C
    Am J Nephrol; 2018; 48(6):425-433. PubMed ID: 30463079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative treatment, hemodialysis or peritoneal dialysis for elderly patients: The choice of treatment does not influence the survival].
    Rouveure AC; Bonnefoy M; Laville M
    Nephrol Ther; 2016 Feb; 12(1):32-7. PubMed ID: 26631312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.
    Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW
    Am J Kidney Dis; 2013 Jan; 61(1):96-103. PubMed ID: 22901771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and cons.
    Biesenbach G; Pohanka E
    Minerva Urol Nefrol; 2012 Sep; 64(3):173-82. PubMed ID: 22971682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients.
    Zee J; Zhao J; Subramanian L; Perry E; Bryant N; McCall M; Restovic Y; Torres D; Robinson BM; Pisoni RL; Tentori F
    BMC Nephrol; 2018 Oct; 19(1):298. PubMed ID: 30373558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.